Left ventricular dysfunction due to diffuse multiple vessel coronary artery spasm can be concealed in dilated

Takumi Inami1, Masaharu Kataoka, Nobuhiko Shimura

  • 1Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Insights

Coronary multispasm may be misdiagnosed as idiopathic dilated cardiomyopathy (DCM). Acetylcholine provocation tests identified spasm, and calcium channel blockers improved left ventricular (LV) function in affected patients.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Medical Diagnostics

Background:

  • Idiopathic dilated cardiomyopathy (DCM) is often diagnosed by excluding coronary artery disease and identifying left ventricular (LV) dysfunction.
  • Coronary artery multispasm is investigated as a potential cause of DCM-like LV dysfunction.

Purpose of the Study:

  • To investigate coronary multispasm as a cause of idiopathic DCM.
  • To assess the efficacy of calcium channel blockers in patients with LV dysfunction due to coronary multispasm.

Main Methods:

  • Forty-two patients with LV dysfunction and no significant coronary stenosis underwent acetylcholine (ACh) provocation testing during coronary angiography.
  • Patients were categorized based on ACh test results (positive or negative).
  • Left ventricular function, MRI, and LV biopsies were assessed. Treatment response to calcium channel blockers was evaluated in the positive group.

Main Results:

  • Twenty patients (48%) had a positive ACh test, showing multivessel coronary spasm and ECG changes.
  • Patients with a negative ACh test more frequently showed idiopathic DCM findings on MRI (73%) and LV biopsy (71%).
  • In the ACh-positive group, LV ejection fraction improved significantly (34% to 54%) after calcium channel blocker treatment, with reduced brain natriuretic peptide levels.

Conclusions:

  • Coronary multispasm may be misdiagnosed as idiopathic DCM.
  • Acetylcholine provocation testing can identify patients with coronary multispasm.
  • Calcium channel blockers represent a potential therapeutic strategy for these patients.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...